University Of Chicago

Black patients with metastatic triple-negative breast cancer received immunotherapy less frequently than patients of other racial or ethnic backgrounds, according to results of a retrospective cohort study.

SAN ANTONIO — The addition of anthracyclines to adjuvant taxane-based chemotherapy improved survival for certain high-risk patients with breast cancer, according to data presented at San Antonio Breast Cancer Symposium.

A new initiative to rapidly place individuals with acute myeloid leukemia or myelodysplastic syndrome in clinical trials based on their genomic profiles has opened in the United States and Canada.

Women with hypothyroidism receiving levothyroxine treatment experienced similar cognitive decline during menopause as those without thyroid disease, according to data published in Thyroid.

BOSTON — Most adults with hypothyroidism prefer combination therapy with liothyronine plus levothyroxine over levothyroxine alone, but most trials find combination therapy provides limited added benefit, according to two speakers.

Hypertension expert and longtime editorial board member for Healio | Cardiology and Healio | Endocrinology George L. Bakris, MD, died June 15, 2024, at the age of 72.

Momentous strides have been made in the understanding of disease biology for many cancer types.

PHILADELPHIA — Zilebesiran, an investigational subcutaneous RNA interference therapeutic, lowered systolic blood pressure at 3 months and sustained the reduction to 6 months, according to results of the phase 2 KARDIA-1 trial.

At 2 years, women who had received relugolix combination therapy for 52 weeks and then withdrew therapy continued to have less menstrual blood loss and pain caused by uterine fibroids, researchers reported.

MADRID — The addition of nivolumab to neoadjuvant chemotherapy, followed by adjuvant nivolumab, improved outcomes for patients with untreated resectable non-small cell lung cancer, randomized phase 3 study results showed.